Type 1 Diabetes (Autoimmune) and Vitamin D, Vitamin D Receptor and Cathelicidin
The roles of vitamin D and cathelicidin on type 1 diabetes susceptibility
Review Endocr Connect, 2020 Dec 1;EC-20-0484.R1. doi: 10.1530/EC-20-0484
Cecília Cristelo 1, Alexandra Machado 2, Bruno Sarmento 3, Francisco Miguel Gama 4
📄 Download the PDF from VitaminDWiki
Type 1 diabetes has increasingly greater incidence and prevalence with no cure available. Vitamin D supplementation is well documented to reduce the risk of developing type 1 diabetes. Being involved in the modulation of cathelicidin expression, the question whether cathelicidin may be one of the underlying cause arises. Cathelicidin has been implicated in both the development and the protection against type 1 diabetes by mediating the interplay between the gut microbiome, the immune system and β cell function. While its potential on type 1 diabetes treatment seems high, the understanding of its effects is still limited. This review aims to contribute to a more comprehensive understanding of the potential of vitamin D and cathelicidin as adjuvants in type 1 diabetes therapy.